Gene Query: HOMER1

Dataset Description Geneva Score
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 49.21
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 49.21
Transcriptomic profiling of human peripheral blood-derived mast cells 35.85
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 35.85
R430: A potent inbibitor of DNA and RNA viruses 35.82
RNAseq Analysis in glioblastoma cells treated with Mepazine 34.41
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 30.39
Differentially expressed genes post knock down of lincDUSP26 30.22
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 28.52
Oncogenic MYC induces a dependency on the spliceosome in human cancer 24.76
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 24.69
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 23.8
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 21.1
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 21.1
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 20.9
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 20.55
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 20.29
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 20.29
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 19.71
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 19.59
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 17.32
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 16.45
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 16.45
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 16.21
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 15.87
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 15.54
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 15.54
Total RNA-seq in ALL-SIL upon TLX1 knockdown 15.39
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 15.37
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 15.28
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 15.22
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 15.13
The role of CFTR in islet function 14.42
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 13.92
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 13.63
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 13.45
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 12.95
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 12.91
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 12.91
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 12.7
Altering cancer transcriptomes using epigenomic inhibitors 12.7
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 12.53
Selective suppression of endothelial cytokine production by progesterone receptor 12.53
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 12.16
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 12.11
ARID1A regulates condensin II distribution and chromosomal partition 12.07
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 12.07
Toxoplasma gondii infection of human retinal pigment epithelial cells 11.87
A549 cell transcriptome responses to infection with H7N9 influenza virus 11.38
Gene expression changes caused by KRAS in MCF-10A 10.97
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 10.87
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 10.74
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 10.74
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 10.74
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 10.64
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 10.39
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 10.39
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 9.86
Identification of global regulators of T-helper cell lineage specification 9.86
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 9.71
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 9.65
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 9.63
RNA expression following TMPRSS11B overexpression or depletion 9.61
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 9.47
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 9.42
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 9.42
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 9.38
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 9.19
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 8.84
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 8.79
BET bromodomain inhibition 8.79
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 8.78
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 8.78
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 8.75
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 8.75
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 8.7
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 8.69
AMPK signaling for naïve pluripotency [Hs] 8.67
AMPK signaling for naïve pluripotency 8.67
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 8.57
IL-33 activates tumor stroma to promote intestinal polyposis 8.49
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 8.37
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 8.37
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 8.3
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 8.23
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 8.22
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 8.2
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 8.19
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 8.15
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 8.05
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 8.05
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 8.03
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 8.0
Knockdown of ADNP in HCT116 colon cancer cells 7.97
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 7.92
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 7.91
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 7.88
IMP3 regulated gene expression in breast cancer cells 7.77
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 7.75
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 7.73
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 7.68
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 7.64
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 7.64
Impact of dieldrin on transcription in Jurkat T cells 7.56
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 7.55
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 7.5
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 7.5
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 7.48
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 7.37
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 7.37
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 7.37
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 7.32
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 7.32
Transcriptome analysis of H9 hESC derived cerebral organoids 7.27
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 7.25
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 7.23
Cerebellar differentiation in Ataxia-Telangiectasia 7.17
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 7.14
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 7.14
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 7.11
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 7.11
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 7.03
Transcriptional profiling of LS1034 cells treated with tepoxalin 6.93
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 6.89
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 6.88
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 6.87
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 6.86
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 6.84
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 6.82
Global expression profiles in cardiac progenitor cells generated by ISX-9 6.82
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 6.81
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 6.8
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 6.78
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 6.78
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 6.77
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 6.69
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 6.68
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 6.61
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 6.57
PNET animal model: new insights (II) 6.56
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 6.56
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 6.53
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 6.41
Peptidomimetic blockade of MYB in acute myeloid leukemia 6.37
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 6.37
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 6.37
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 6.37
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 6.37
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 6.35
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 6.3
RNA-seq analysis of RALD iPSCs after in vitro differentiation 6.29
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 6.19
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 6.15
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 6.15
The pause-initiation limit restricts transcription activation in human cells 6.12
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 6.09
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 6.07
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 6.05
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 6.05
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 6.04
Global Mapping of Human RNA-RNA Interactions 6.0
High-efficiency RNA-based reprogramming of human primary fibroblasts 5.88
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 5.87
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 5.84
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 5.83
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 5.82
A transcriptome-wide divergence in protein translation scales with LIN28B expression 5.76
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 5.75
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 5.75
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 5.75
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 5.73
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 5.69
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 5.69
The effect of insulin on mRNA transcription of human pluripotent stem cells 5.69
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 5.65
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 5.62
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 5.62
The cohesin complex prevents Myc-induced replication stress 5.61
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 5.58
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 5.58
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.55
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 5.54
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 5.54
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 5.53
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 5.51
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 5.42
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 5.42
mRNA-sequencing of breast cancer subtypes and normal tissue 5.42
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 5.35
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 5.32
Differentially expressed vascular development genes for iPSC-ECs from CDI 5.27
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  5.25
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 5.25
Gene expression analysis in response to hypoxic pathway inhibition 5.22
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 5.21
Gene expression analysis of the impact of TDP-43 knockout in human cells. 5.2
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 5.17
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 5.16
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 5.16
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 5.16
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 5.15
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 5.12
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 5.12
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 5.08
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 5.08
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 5.06
RNA-seq data from human lymphoma cell lines 5.03
ChIP-seq and RNA-seq from human lymphoma cell lines 5.03
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 5.02
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 4.94
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 4.93
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 4.93
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 4.9
MYCL and EP400 are required for Max and MCPyV mediated gene activation 4.88
Human cell line and subcutaneous tumor 4.87
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 4.84
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 4.84
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 4.84
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 4.84
iPSC-Derived Cholangiocytes 4.83
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 4.81
RNA-seq of naive and primed ES cells (NHSM) 4.81
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 4.78
Transcriptomic analysis of frontal fibrosing alopecia 4.77
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 4.73
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 4.73
circRNA-sequencing 4.7
RNAseq of T-ALL upon long non coding rna purturbation 4.7
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 4.68
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 4.65
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 4.64
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 4.64
RNA expression analysis upon JMJD1C depletion 4.63
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 4.63
The landscape of alternative splicing in aggressive prostate cancers 4.61
SNHG5 siRNA knock down in HCT116 cells 4.61
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 4.6
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 4.59
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 4.57
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 4.57
The Human Testis Cell Atlas via Single-cell RNA-seq 4.56
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 4.56
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 4.55
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 4.51
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 4.48
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 4.48
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 4.47
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.45
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.45
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 4.43
EWS-Fli and LNC regulated genes in comparison to GFP samples 4.41
Zika virus infection reprograms global transcription of host cells to allow sustained infection 4.41
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 4.41
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 4.41
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 4.41
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 4.4
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 4.4
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 4.39
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 4.35
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 4.28
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 4.28
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 4.26
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 4.25
The age and genomic integrity of neurons after cortical stroke in humans 4.22
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 4.15
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 4.13
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 4.12
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 4.12
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 4.12
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 4.1
Global analysis of alternative splicing regulated by RBM10 4.09
Gene expression in GBM with Cav3.2 inhibition 4.06
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 4.05
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 4.05
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 4.05
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 4.03
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 4.03
RNA-seq of YB5 cells treated with Proscillaridin A 4.03
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 3.98
RNA-Seq from early time points in the kidney differentiation protocol 3.97
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 3.96
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.95
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 3.94
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 3.93
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 3.93
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 3.86
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 3.78
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 3.77
Effect of disulfiram treatment on pediatric high grade glioma 3.73
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 3.72
circRNA profile in hypopharyngeal cancer 3.68
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 3.68
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 3.62
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 3.62
PGE2 mediated gene expression changes in human cervical stromal cells 3.61
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 3.59
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 3.59
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 3.55
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 3.55
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 3.54
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 3.51
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 3.48
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 3.48
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 3.45
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 3.45
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 3.45
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 3.38
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 3.38
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 3.38
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 3.36
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 3.33
Noncoding regions are the main source of targetable tumor-specific antigens 3.32
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 3.31
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 3.31
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 3.3
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 3.24
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 3.23
RNA seq comparison between scrambled and shGRP78 cells 3.22
Investigation about fibroblasts of different origins in culture 3.21
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 3.2
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 3.17
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 3.15
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 3.14
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 3.14
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 3.14
Recovery and analysis of nascent RNA 3.14
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.12
Transcriptome of human white and brown adipose tissue biopsies 3.09
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.07
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.07
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 3.06
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 3.06
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 3.04
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 3.01
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 3.01
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 3.01
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 2.9
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 2.88
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 2.88
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.87
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 2.84
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 2.81
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 2.8
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.73
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 2.71
RNA Sequencing of Human iPS derived Cardiomyocytes 2.69
2.66
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.65
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 2.64
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 2.6
Dilated cardiomyopathy vs Myocarditis 2.53
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.52
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 2.47
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 2.45
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 2.45
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 2.45
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.45
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 2.45
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 2.45
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 2.42
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 2.41
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 2.39
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 2.35
Identification of expressed and conserved human non-coding RNAs 2.3
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 2.2
Gene expression profile of human iPSC-derived nephron progenitor cells 2.18
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.17
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 2.15
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 2.15
Oncogenic roles of ARID5B in T-ALL 2.15
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 2.15
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 2.13
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 2.12
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 2.08
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 2.08
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 2.06
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.06
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 2.01
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 2.01
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 2.01
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 1.95
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 1.95
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.93
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.93
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.93
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 1.92
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.89
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.89
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 1.88
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 1.88
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.87
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.85
MHC Transcriptomic landscape at haplotype-specific resolution 1.85
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.82
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.82
hESC neural differentiation 1.81
RNA-seq analysis of gene expression patterns during hESC neural differentiation 1.81
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 1.75
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 1.75
Single cell transcriptome of peritoneal cells 1.75
The transcriptome of Kawasaki Disease arteritis 1.75
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.73
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 1.72
Real-time observation of light-controlled transcription in living cells 1.72
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 1.71
RNAseq in Alzheimer's Disease patients 1.7
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 1.7
SOX11 knockdown in B-ALL cell lines 1.69
BI Human Reference Epigenome Mapping Project 1.65
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 1.65
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 1.61
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 1.61
RNA-seq analysis of control and Myc-induced U2OS cells 1.59
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 1.58
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 1.57
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 1.57
SLAM-seq for K562 endogenous mRNA decay 1.56
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 1.52
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 1.52
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 1.5
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 1.49
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 1.46
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 1.46
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 1.43
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 1.43
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 1.4
Activity-dependent transcriptional changes in human neurons 1.39
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.34
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.27
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 1.22
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.2
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 1.14
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 1.12
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 1.08
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.06
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.06
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 1.04
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.03
Dynamic 3D chromosomal landscapes in acute leukemia 0.98
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 0.98
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 0.96
Dissecting neural differentiation regulatory networks through epigenetic footprinting 0.95
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.92
Single-cell analysis of adult human ovary using 10X genomics 0.86
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.77
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.76
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.73
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.7
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 0.69
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.68
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.66
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.66
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 0.65
Modeling Human Cancer-induced Cachexia (Human) 0.64
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 0.61
The contribution of Alu exons to the human proteome 0.6
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 0.59
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 0.59
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.56
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.55
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 0.55
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 0.55
Mapping interactions for the TNIP2 hub protein 0.55
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 0.51
RNA sequencing of matched nephrectomy samples [RNA-seq] 0.51
Human ovarian granulosa cell transcriptome 0.51
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.51
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.5
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.47
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.47
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.47
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 0.42
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.42
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.42
Identification of long noncoding RNAs in T-ALL cell lines 0.38
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.37
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.36
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.35
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 0.35
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.34
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 0.23
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 0.23
Transcriptional landscape changes during human embryonic stem cell derivation 0.22
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.19
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.18
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.16
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.12
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 0.11
Preclinical model of obesity and ER-positive breast cancer 0.1
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.1
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.09
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 0.09
KSDM1b Role in Ewing Sarcoma 0.06
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.05
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.04
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.03
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 0.03
LINE-2 transposable elements are a source of functional human microRNAs and target sites 0.02
Modulation of nonsense-mediated decay by rapamycin 0.01
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation